NICE Recommends Tisagenlecleucel for Pediatric R/R B-ALL : c

The National Institute for Health and Care Excellence has recommended the use of tisagenlecleucel in pediatric B-cell acute lymphoblastic leukemia.

Related Keywords

United Kingdom , Helen Knight , National Health Service , Cancer Drugs Fund , United Kingdom National Institute For Health , National Institute For Health Care Excellence , National Institute , Care Excellence , Health Care , Pediatricb Cell Acute Lymphoblastic Leukemia , National Institute For Health And Care Excellence , Tisagenlecleucel ,